Crux Wealth Advisors Boosts Stake in UnitedHealth Group Incorporated $UNH

Crux Wealth Advisors raised its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 10.6% in the second quarter, Holdings Channel reports. The fund owned 2,002 shares of the healthcare conglomerate’s stock after buying an additional 192 shares during the period. Crux Wealth Advisors’ holdings in UnitedHealth Group were worth $625,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the stock. Chicago Partners Investment Group LLC lifted its position in UnitedHealth Group by 26.4% during the second quarter. Chicago Partners Investment Group LLC now owns 4,606 shares of the healthcare conglomerate’s stock worth $1,347,000 after buying an additional 962 shares in the last quarter. Sigma Investment Counselors Inc. raised its holdings in shares of UnitedHealth Group by 5.8% during the 2nd quarter. Sigma Investment Counselors Inc. now owns 14,130 shares of the healthcare conglomerate’s stock worth $4,408,000 after acquiring an additional 769 shares during the period. Sims Investment Management LLC grew its holdings in shares of UnitedHealth Group by 3.9% in the second quarter. Sims Investment Management LLC now owns 1,087 shares of the healthcare conglomerate’s stock valued at $339,000 after purchasing an additional 41 shares during the period. Flavin Financial Services Inc. raised its stake in UnitedHealth Group by 3.8% during the second quarter. Flavin Financial Services Inc. now owns 4,981 shares of the healthcare conglomerate’s stock worth $1,554,000 after purchasing an additional 181 shares during the period. Finally, BKM Wealth Management LLC grew its stake in shares of UnitedHealth Group by 29.3% in the 2nd quarter. BKM Wealth Management LLC now owns 5,726 shares of the healthcare conglomerate’s stock valued at $1,786,000 after buying an additional 1,296 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Trading Down 0.0%

Shares of UNH stock opened at $356.53 on Friday. The stock has a market capitalization of $322.90 billion, a P/E ratio of 15.45, a price-to-earnings-growth ratio of 2.31 and a beta of 0.47. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $630.73. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. The company has a 50 day moving average price of $329.38 and a 200 day moving average price of $343.62.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). The business had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The business’s revenue was up 12.9% on a year-over-year basis. During the same quarter last year, the firm earned $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were paid a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.5%. The ex-dividend date was Monday, September 15th. UnitedHealth Group’s dividend payout ratio is presently 38.30%.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on UNH. Bank of America upped their price objective on UnitedHealth Group from $350.00 to $390.00 and gave the company a “neutral” rating in a report on Wednesday, October 8th. Barclays increased their price target on UnitedHealth Group from $352.00 to $386.00 and gave the stock an “overweight” rating in a report on Thursday, October 9th. Piper Sandler decreased their target price on shares of UnitedHealth Group from $353.00 to $317.00 and set an “overweight” rating on the stock in a research report on Wednesday, July 30th. Sanford C. Bernstein boosted their price target on shares of UnitedHealth Group from $379.00 to $433.00 and gave the company an “outperform” rating in a research note on Wednesday, October 8th. Finally, Weiss Ratings reiterated a “sell (d+)” rating on shares of UnitedHealth Group in a report on Wednesday, October 8th. Eighteen analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and four have assigned a Sell rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $385.13.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.